Gynecology and Lubricant Effects (GALE) Study

Request Access

Anthropometry (1)

BMI - Body mass index (phv00532639.v1.p1)

Demographics (2)

AGE - Subject age at enrollment (phv00435757.v2.p1)
SEX - Biological sex (phv00435697.v2.p1)

Race and Ethnicity (8)

DE02RACE1 - Self-reported race: White (phv00531516.v1.p1)
DE02RACE2 - Self-reported race: Black or African American (phv00531517.v1.p1)
DE02RACE3 - Self-reported race: Native American or Alaskan Native (phv00531518.v1.p1)
DE02RACE4 - Self-reported race: Native Hawaiian or Pacific Islander (phv00531519.v1.p1)
DE02RACE5 - Self-reported race: Asian (phv00531520.v1.p1)
DE02RACE9996 - Self-reported race: Other (phv00531521.v1.p1)
DE02RACE9997 - Self-reported race: Unknown (phv00531522.v1.p1)
HISPANIC - Self-reported ethnicity (phv00435756.v2.p1)

Reproductive Health (50)

CE05VDISCH - From clinical visit: vaginal discharge (including physiologic discharge) (phv00537676.v1.p1)
CE09PH - From clinical visit: vaginal pH (phv00537677.v1.p1)
DAYSSINCELMP - Self-reported days since last mentrual period from enrollment (phv00532660.v1.p1)
DD01VAGSEX - Vaginal intercourse (phv00532677.v1.p1)
DD02ANALSEX - Receptive anal intercourse (phv00537672.v1.p1)
DD03ORALSEX - Receptive oral intercourse (phv00537673.v1.p1)
DD17ODOR - Vaginal odor (phv00532678.v1.p1)
DD18IRRITATION - Vaginal irritation (phv00532679.v1.p1)
DD19ITCHING - Vaginal itching (phv00532680.v1.p1)
DD20BURNING - Vaginal burning (phv00532681.v1.p1)
DD21URINATION - Pain during urination (phv00532682.v1.p1)
DD22PAINSEX - Pain during intercourse (phv00532683.v1.p1)
DD23DISCHARGE - Vaginal discharge (phv00532684.v1.p1)
DD24MENSES - Menstruation (phv00532686.v1.p1)
DD31DRYNESS - Vaginal dryness (phv00532685.v1.p1)
DDFHYGIENEUSE - Any feminine hygiene product use reported on daily diary (phv00537674.v1.p1)
DDSEXACTIVITY - Any vaginal, anal, or oral intervourse reported on daily diary (phv00537675.v1.p1)
HB02BLMP - Reason for not having a menstrual cycle in past 12 months (phv00532661.v1.p1)
HB03BLMPREG - Have you gone 2 months or more without a cycle in the past year (phv00532663.v1.p1)
HB03CLMPREG - Have you been late or early by approximately 7 days or more in the past year (phv00532664.v1.p1)
HB03LMPREG - In the past 6 months, how regular have your periods been (phv00532662.v1.p1)
HB11DOUCHE - Self-reported ever douching (phv00532657.v1.p1)
HB11DOUCHEFREQ - Self-reported douching frequency in past 2 months (phv00532658.v1.p1)
HB13BCTYPIUD1 - IUD type: progestin-releasing (phv00531547.v1.p1)
HB13BCTYPIUD2 - IUD type: copper-coil (phv00531548.v1.p1)
HB13BCTYPNOW1 - Self-reported birth control: none (phv00531524.v1.p1)
HB13BCTYPNOW10 - Self-reported birth control: contraceptive patch (phv00531533.v1.p1)
HB13BCTYPNOW11 - Self-reported birth control: cervical cap (phv00531534.v1.p1)
HB13BCTYPNOW12 - Self-reported birth control: implants (phv00531535.v1.p1)
HB13BCTYPNOW13 - Self-reported birth control: withdrawal (phv00531536.v1.p1)
HB13BCTYPNOW14 - Self-reported birth control: rhythm or natural family planning (phv00531537.v1.p1)
HB13BCTYPNOW15 - Self-reported birth control: abstinence (phv00531538.v1.p1)
HB13BCTYPNOW16 - Self-reported birth control: partner has vasectomy (phv00531539.v1.p1)
HB13BCTYPNOW17 - Self-reported birth control: tubal ligation (phv00531540.v1.p1)
HB13BCTYPNOW18 - Self-reported birth control: morning after pills (phv00531541.v1.p1)
HB13BCTYPNOW19 - Self-reported birth control: douching (phv00531542.v1.p1)
HB13BCTYPNOW2 - Self-reported birth control: birth control pill (phv00531525.v1.p1)
HB13BCTYPNOW20 - Self-reported birth control: shot (phv00531543.v1.p1)
HB13BCTYPNOW3 - Self-reported birth control: male condom (phv00531526.v1.p1)
HB13BCTYPNOW4 - Self-reported birth control: female condom (phv00531527.v1.p1)
HB13BCTYPNOW5 - Self-reported birth control: contraceptive foam, jelly, cream, or suppositories (phv00531528.v1.p1)
HB13BCTYPNOW6 - Self-reported birth control: vaginal sponge (phv00531529.v1.p1)
HB13BCTYPNOW7 - Self-reported birth control: diaphragm (phv00531530.v1.p1)
HB13BCTYPNOW8 - Self-reported birth control: intrauterine device (IUD) (phv00531531.v1.p1)
HB13BCTYPNOW9 - Self-reported birth control: vaginal ring (phv00531532.v1.p1)
HB15PREGHIST1 - Self-reported ever pregnancy (phv00532655.v1.p1)
HB15PREGHIST2 - Self-reported had at least one vaginal birth (phv00532656.v1.p1)
LUBEBV_CONDOMUSE - Self-reported condom use during follow-up for incident BV analysis (phv00537663.v1.p1)
LUBEBV_DOUCHE_60DAYS - Self-reported vaginal douching in prior 2 months at baseline for incident BV analysis (phv00537662.v1.p1)
REPRODUCTIVE_STAGE - Determination of reproductive stage based on self-reported age and menstruation (phv00532659.v1.p1)

Other (98)

ANALYTE_TYPE - Analyte type (phv00435702.v2.p1)
BODY_SITE - Body site where sample was collected (phv00435701.v2.p1)
CE09CLUEC - From clinical exam: clue cells (phv00537679.v1.p1)
CE09WHIFF - From clinical exam: whiff test (phv00537678.v1.p1)
CE10DIAGNOSIS1 - From clinical exam: diagnosed with asymptomatic Amsel-BV (phv00537680.v1.p1)
CE10DIAGNOSIS2 - From clinical exam: diagnosed with symptomatic Amsel-BV (phv00537681.v1.p1)
CELL_COUNT - Cell count measured from softcup sample (phv00435783.v2.p1)
CELLSHEDDING_RACE - Self-reported race at baseline for cell shedding manuscript (phv00532675.v1.p1)
CONSENT - Consent group (phv00435696.v2.p1)
CST_URINE - Community State Type measured from urine sample (phv00435782.v2.p1)
CST_VAGINAL - Community State Type measured from e-swab sample (phv00435781.v2.p1)
DE02RACEO - Self-reported race: Other specified (phv00531523.v1.p1)
DE06DEGREE - Self-reported education: highest degree earned (phv00532640.v1.p1)
DE06DEGREEO - Self-reported education: specify type of degree earned (phv00532641.v1.p1)
DE07MARITAL - Self-reported marital status (phv00532642.v1.p1)
DE07MARITALO - Self-reported marital status: specify (phv00532643.v1.p1)
DE08INCOMERANGE - Self-reported total household income (phv00532644.v1.p1)
DE11BASICS - Self-reported difficulty paying for basics (phv00532645.v1.p1)
DE12SAVINGS - Self-reported length of time (in months) current savings could support household (phv00532646.v1.p1)
DE13HEALTHSERVICES - Self-reported difficulty paying for health services (phv00532647.v1.p1)
DIARY_NUMBER - Daily diary number. Day 0 represents baseline (phv00532676.v1.p1)
EVENT - Type of clinical visit. No clinical visit on that day if blank. (phv00435780.v2.p1)
FIBROID_CASECONTROL - Flag to indicate participant is case or control in fibroid manuscript (phv00532665.v1.p1)
FIBROID_CC_3LEVEL - Community class of vaginal microbiota before TVUS for fibroid manuscript with 3 levels (phv00532667.v1.p1)
FIBROID_CC_5LEVEL - Community class of vaginal microbiota before TVUS for fibroid manuscript with 5 levels (phv00532668.v1.p1)
FIBROID_CONTRA - Use of hormonal contraception self-reported at baseline for fibroid manuscript (phv00532669.v1.p1)
FIBROID_PRETVUS_MENSES - Self-reported menses during sampling before TVUS for fibroid manuscript (phv00532666.v1.p1)
FIBROID_RACE - Self-reported any Black race at baseline for fibroid manuscript (phv00532670.v1.p1)
GINI - Census-based measure of dispersion of household income distribution within a locality (phv00532650.v1.p1)
HB09BV - Self reported last time being diagnosed with bacterial vaginosis (phv00537656.v1.p1)
HB13BCTYPNOW9996 - Self-reported birth control: other (phv00531544.v1.p1)
HB13BCTYPNOW9998 - Self-reported birth control: prefer not to answer (phv00531545.v1.p1)
HB13BCTYPO - Self-reported birth control: other specified (phv00531546.v1.p1)
HB24FEMALESEXEVER - Self-reported number of lifetime female sexual partners (phv00537658.v1.p1)
HB24MALESEXEVER - Self-reported number of lifetime male sexual partners (phv00537657.v1.p1)
HB25FEMALESE2MO - Self-reported number of female sexual partners in prior 2 months (phv00537660.v1.p1)
HB25MALESEX2MO - Self-reported number of male sexual partners in prior 2 months (phv00537659.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00435703.v2.p1)
HSEDUCATION - Census-based proportion of the population with less than high school education (phv00532652.v1.p1)
IS_TUMOR - Tumor status (phv00435704.v2.p1)
LUBEBV_NEWBV - New-onset Amsel-BV in incident BV manuscript (phv00537666.v1.p1)
LUBEBV_NEWBVNEWSYMP - New-onset/newly-symptomatic Amsel-BV in incident BV manuscript (phv00537667.v1.p1)
LUBEBV_NEWCLUECELLS - New-onset clue cells in incident BV manuscript (phv00537671.v1.p1)
LUBEBV_NEWDISCH - New-onset thin homogenous discharge in incident BV manuscript (phv00537668.v1.p1)
LUBEBV_NEWHIGHPH - New-onset pH > 4.5 in incident BV manuscript (phv00537669.v1.p1)
LUBEBV_NEWWHIFF - New-onset positive whiff test in incident BV manuscript (phv00537670.v1.p1)
LUBEBV_RACE - Self-reported only Black race at baseline for incident BV manuscript (phv00537661.v1.p1)
LUBEBV_SEXPARTNER_60DAYS - Self-reported number of sexual partners in prior 2 months at baseline for incident BV analysis (phv00537665.v1.p1)
LUBEBV_SEXPARTNER_LIFETIME - Self-reported lifetime number of sexual partners at baseline for incident BV analysis (phv00537664.v1.p1)
LUBEVMB_LOWSCORECST - From lubricant and vaginal microbiota analysis: CST assignment was below 5th percentile for similarity scores from VALENCIA training dataset (phv00537684.v1.p1)
LUBEVMB_POSTABXAF - From lubricant and vaginal microbiota analysis: sample was taken after antibiotic or antifungal use (phv00537682.v1.p1)
LUBEVMB_POSTLUBRICANT - From lubricant and vaginal microbiota analysis: sample was taken after additional lubricant use (phv00537683.v1.p1)
LUBEVMB_PREPOST - From lubricant and vaginal microbiota analysis: indicator for sample being before or after TVUS (phv00537685.v1.p1)
LUBEVMB_STABILITYPHASE - From lubricant and vaginal microbiota analysis: interval for stability analysis (phv00537686.v1.p1)
LUBEVMB_WINDOW1 - From lubricant and vaginal microbiota analysis: indicator for sample being in Week 0 or Weeks 1-4 (phv00537687.v1.p1)
LUBEVMB_WINDOW2 - From lubricant and vaginal microbiota analysis: indicator for sample being in Week 0 or Weeks 2-5 (phv00537688.v1.p1)
LUBEVMB_WINDOW3 - From lubricant and vaginal microbiota analysis: indicator for sample being in Week 0 or Weeks 3-6 (phv00537689.v1.p1)
LUBEVMB_WINDOW4 - From lubricant and vaginal microbiota analysis: indicator for sample being in Week 0 or Weeks 4-7 (phv00537690.v1.p1)
LUBEVMB_WINDOW5 - From lubricant and vaginal microbiota analysis: indicator for sample being in Week 0 or Weeks 5-8 (phv00537691.v1.p1)
LUBEVMB_WINDOW6 - From lubricant and vaginal microbiota analysis: indicator for sample being in Week 0 or Weeks 6-9 (phv00537692.v1.p1)
MATURITY_INDEX - Maturity index (MI) measured from softcup sample (phv00435784.v2.p1)
MEDIANINCOME - Census-based median household income (phv00532648.v1.p1)
MENOPAPER_CLASSES - Community classes assigned for Menopause manuscript (phv00532673.v1.p1)
MENOPAPER_YUECLAYTON - Mean Yue Clayton similarity score assigned for Menopause manuscript (phv00532674.v1.p1)
MI_CAT - Maturity index (MI) category based on pre-TVUS softcup sample MI (phv00435785.v2.p1)
NOVEHICLE - Census-based proportion of the population with no vehicle (phv00532653.v1.p1)
POVERTY - Census-based proportion of the population where household income was at or below poverty level (phv00532651.v1.p1)
SAMPLE_ID - Sample ID (phv00435700.v2.p1)
SAMPLE_ID - Sample ID (phv00435699.v2.p1)
SES_SCORE_BINARY - Composite score of socioeconomic status for SES manuscript (phv00532672.v1.p1)
SESPAPER_CLASSES - Community classes assigned for SES manuscript (phv00532671.v1.p1)
STUDY_DAY - Day in study. Day 0 represents TVUS appointment (phv00435778.v2.p1)
SUBJECT_ID - Subject ID (phv00435754.v2.p1)
SUBJECT_ID - Subject ID (phv00435777.v2.p1)
SUBJECT_ID - Subject ID (phv00435695.v2.p1)
SUBJECT_ID - Subject ID (phv00435698.v2.p1)
SWAB_NUMBER - Indicator for pre-TVUS and post-TVUS sample on day of TVUS (phv00435779.v2.p1)
TV01INDIC1 - Indication for TVUS: assessment of a pelvic mass (e.g., adenomyosis, fibroid, cancer, cysts) (phv00531549.v2.p1)
TV01INDIC10 - Indication for TVUS: other (phv00531558.v2.p1)
TV01INDIC2 - Indication for TVUS: evaluation of the menstrual cycle (endometrial thickness, follicular development) (phv00531550.v2.p1)
TV01INDIC3 - Indication for TVUS: infertility therapy (phv00531551.v2.p1)
TV01INDIC4 - Indication for TVUS: localization of an intrauterine device (phv00531552.v2.p1)
TV01INDIC5 - Indication for TVUS: evaluation of abnormal uterine bleeding (e.g., menorrhagia) (phv00531553.v2.p1)
TV01INDIC6 - Indication for TVUS: evaluation for sequelae of pelvic infection (e.g., abscess, hydrosalpinx) (phv00531554.v2.p1)
TV01INDIC7 - Indication for TVUS: evaluation of congenital uterine anomalies (phv00531555.v2.p1)
TV01INDIC8 - Indication for TVUS: screening for malignancy (phv00531556.v2.p1)
TV01INDIC9 - Indication for TVUS: pelvic pain (phv00531557.v2.p1)
TV01INDICO - Specify other indication for TVUS (phv00435768.v2.p1)
TV02FIND0 - TVUS findings: no significant findings (phv00531565.v2.p1)
TV02FIND1 - TVUS findings: adenomyosis (phv00531559.v2.p1)
TV02FIND2 - TVUS findings: fibroids (phv00531560.v2.p1)
TV02FIND3 - TVUS findings: cysts (phv00531561.v2.p1)
TV02FIND4 - TVUS findings: pelvic inflammatory disease (phv00531562.v2.p1)
TV02FIND5 - TVUS findings: cancer (phv00531563.v2.p1)
TV02FIND6 - TVUS findings: other (phv00531564.v2.p1)
TV02OTHER - Specify other findings for TVUS (phv00435776.v2.p1)
UNEMPLOYMENT - Census-based proportion of population without employment (phv00532649.v1.p1)
WORKINGCLASS - Census-based proportion of the population with working class occupation (phv00532654.v1.p1)